Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells

Molecular and Cellular Biochemistry

Volumn 403, Issue 1-2, 2015, Pages 95-106

  Patil, Rajeshwari H ^a   Babu, R L ^a   Naveen Kumar, M ^a   Kiran Kumar, K M ^a   Hegde, Shubha M ^a   Ramesh, Govindarajan T ^b   Chidananda Sharma, S ^a  

^a BANGALORE UNIVERSITY   (India)

^b NORFOLK STATE UNIVERSITY   (United States)

Author keywords

A549; AP 1; Apigenin; Cytokines; Phorbol 12 myristate 13 acetate; qRT PCR

Indexed keywords

APIGENIN; AUTACOID; CELL CYCLE PROTEIN; CYCLOOXYGENASE 2; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

APIGENIN; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOOXYGENASE 2; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

EID: 84940007173     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2340-3     Document Type: Article

References (43)

1. Dinarello CA (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321s–329s
2. Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL (2003) Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2:736–746. doi:10.1038/nrd1175
3. Levine SJ (1995) Bronchial epithelial cell-cytokine interactions in airway inflammation. J Investig Med 43:241–249
4. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245–270. doi:10.1146/annurev.med.51.1.245
5. Arnold R, Humbert B, Werchau H, Gallati H, Konig W (1994) Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82:126–133
6. Esposito E, Cuzzocrea S (2007) The role of nitric oxide synthases in lung inflammation. Curr Opin Investig Drugs 8:899–909
7. Murakami A, Ohigashi H (2007) Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121:2357–2363. doi:10.1002/ijc.23161
8. Mitchell JA, Larkin S, Williams TJ (1995) Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 50:1535–1542
9. Nathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78:915–918
10. Papavassiliou AG (1995) Transcription factors: structure, function, and implication in malignant growth. Anticancer Res 15:891–894
11. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725–734. doi:10.1038/nri910
12. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280–288. doi:10.1016/j.it.2004.03.008
13. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136. doi:10.1038/ncb0502-e131
14. Guo RF, Lentsch AB, Sarma JV, Sun L, Riedemann NC, McClintock SD, McGuire SR, Van Rooijen N, Ward PA (2002) Activator protein-1 activation in acute lung injury. Am J Pathol 161:275–282. doi:10.1016/s0002-9440(10)64179-x
15. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS (1993) Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104:1832–1847
16. Maruta A, Enaka K, Umeda M (1979) Mutagenicity of quercetin and kaempferol on cultured mammalian cells. Gann 70:273–276
17. Wei H, Tye L, Bresnick E, Birt DF (1990) Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50:499–502
18. Hirano T, Oka K, Akiba M (1989) Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol 64:69–78
19. Nielsen SE, Young JF, Daneshvar B, Lauridsen ST, Knuthsen P, Sandstrom B, Dragsted LO (1999) Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr 81:447–455
20. Babu RL, Naveen Kumar M, Patil RH, Devaraju KS, Ramesh GT, Sharma SC (2013) Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation. Mol Cell Biochem 380:143–151. doi:10.1007/s11010-013-1667-x
21. Sharma CS, Sarkar S, Periyakaruppan A, Barr J, Wise K, Thomas R, Wilson BL, Ramesh GT (2007) Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells. J Nanosci Nanotechnol 7:2466–2472
22. Periyakaruppan A, Kumar F, Sarkar S, Sharma CS, Ramesh GT (2007) Uranium induces oxidative stress in lung epithelial cells. Arch Toxicol 81:389–395. doi:10.1007/s00204-006-0167-0
23. Eigler A, Moeller J, Endres S (1995) Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol 154:4048–4054
24. Sharma SC, Clemens JW, Pisarska MD, Richards JS (1999) Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin. Endocrinology 140:4320–4334. doi:10.1210/endo.140.9.6965
25. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
26. Kim SJ, Jeong HJ, Moon PD, Lee KM, Lee HB, Jung HJ, Jung SK, Rhee HK, Yang DC, Hong SH, Kim HM (2005) Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-kappa B activation in peritoneal macrophages. Biol Pharm Bull 28:233–237
27. Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T (2005) Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep 57:390–394
28. Lee JH, Zhou HY, Cho SY, Kim YS, Lee YS, Jeong CS (2007) Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch Pharm Res 30:1318–1327
29. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI (2007) Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 179:7121–7127
30. Jeong GS, Lee SH, Jeong SN, Kim YC, Kim EC (2009) Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1. Int Immunopharmacol 9:1374–1380. doi:10.1016/j.intimp.2009.08.015
31. MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15:323–350. doi:10.1146/annurev.immunol.15.1.323
32. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907–916. doi:10.1038/ni1001-907
33. Hobbs AJ, Higgs A, Moncada S (1999) Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39:191–220. doi:10.1146/annurev.pharmtox.39.1.191
34. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20:1945–1952
35. Vane SJ (1998) Differential inhibition of cyclooxygenase isoforms: an explanation of the action of NSAIDs. J Clin Rheumatol 4:s3–s10
36. Jachak SM (2006) Cyclooxygenase inhibitory natural products: current status. Curr Med Chem 13:659–678
37. Ohshima H, Bartsch H (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305:253–264
38. Krakauer T (2004) Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB. Curr Drug Targets Inflamm Allergy 3:317–324
39. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Mueller C (1994) Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 144:997–1007
40. Milde-Langosch K, Kappes H, Riethdorf S, Loning T, Bamberger AM (2003) FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas. Breast Cancer Res Treat 77:265–275
41. Morrissey C, O’Neill A, Spengler B, Christoffel V, Fitzpatrick JM, Watson RW (2005) Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells. Prostate 63:131–142. doi:10.1002/pros.20167
42. Yoon JH, Baek SJ (2005) Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J 46:585–596
43. Lewis TS, Shapiro PS, Ahn NG (1998) Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49–139